JP2016534143A5 - - Google Patents

Download PDF

Info

Publication number
JP2016534143A5
JP2016534143A5 JP2016542643A JP2016542643A JP2016534143A5 JP 2016534143 A5 JP2016534143 A5 JP 2016534143A5 JP 2016542643 A JP2016542643 A JP 2016542643A JP 2016542643 A JP2016542643 A JP 2016542643A JP 2016534143 A5 JP2016534143 A5 JP 2016534143A5
Authority
JP
Japan
Prior art keywords
carbonyl
phthalazin
azetidine
fluoro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542643A
Other languages
English (en)
Japanese (ja)
Other versions
JP6180643B2 (ja
JP2016534143A (ja
Filing date
Publication date
Priority claimed from KR1020140120152A external-priority patent/KR101670126B1/ko
Application filed filed Critical
Publication of JP2016534143A publication Critical patent/JP2016534143A/ja
Publication of JP2016534143A5 publication Critical patent/JP2016534143A5/ja
Application granted granted Critical
Publication of JP6180643B2 publication Critical patent/JP6180643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542643A 2013-09-13 2014-09-12 新規フタラジノン誘導体及びその製造方法「A novel phtalazinone derivatives and manufacturing process thereof」 Active JP6180643B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2013-0110170 2013-09-13
KR20130110170 2013-09-13
KR1020140120152A KR101670126B1 (ko) 2013-09-13 2014-09-11 신규 프탈라지논 유도체 및 그 제조방법
KR10-2014-0120152 2014-09-11
PCT/KR2014/008523 WO2015037939A1 (en) 2013-09-13 2014-09-12 A novel phtalazinone derivatives and manufacturing process thereof

Publications (3)

Publication Number Publication Date
JP2016534143A JP2016534143A (ja) 2016-11-04
JP2016534143A5 true JP2016534143A5 (https=) 2017-06-15
JP6180643B2 JP6180643B2 (ja) 2017-08-16

Family

ID=53024930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542643A Active JP6180643B2 (ja) 2013-09-13 2014-09-12 新規フタラジノン誘導体及びその製造方法「A novel phtalazinone derivatives and manufacturing process thereof」

Country Status (25)

Country Link
US (3) USRE49338E1 (https=)
EP (1) EP3030557B1 (https=)
JP (1) JP6180643B2 (https=)
KR (1) KR101670126B1 (https=)
CN (1) CN105793248B (https=)
AU (1) AU2014319132C1 (https=)
BR (1) BR112016004979B1 (https=)
CA (1) CA2923614C (https=)
DK (1) DK3030557T3 (https=)
ES (1) ES2953834T3 (https=)
FI (1) FI3030557T3 (https=)
HR (1) HRP20230998T1 (https=)
HU (1) HUE062770T2 (https=)
IL (1) IL244548B (https=)
LT (1) LT3030557T (https=)
MX (1) MX379467B (https=)
MY (1) MY195343A (https=)
PL (1) PL3030557T3 (https=)
PT (1) PT3030557T (https=)
RS (1) RS64477B1 (https=)
RU (1) RU2636585C2 (https=)
SG (1) SG11201600549TA (https=)
SI (1) SI3030557T1 (https=)
SM (1) SMT202300268T1 (https=)
WO (1) WO2015037939A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101670126B1 (ko) * 2013-09-13 2016-10-27 일동제약(주) 신규 프탈라지논 유도체 및 그 제조방법
EP3758695A4 (en) * 2018-02-28 2021-10-06 The Trustees Of The University Of Pennsylvania POLY (AD-RIBOSE) -POLYMERASE 1 DEPENDENT CYTOTOXIC AGENTS WITH LOW AFFINITY
JP7626783B2 (ja) * 2020-04-21 2025-02-07 アイディーエンス カンパニー リミテッド フタラジノン誘導体及びその中間体を調製するプロセス
AU2020444056A1 (en) * 2020-04-21 2022-11-17 Idience Co., Ltd. Crystalline forms of phthalazinone compound
WO2021225407A1 (ko) * 2020-05-08 2021-11-11 주식회사 티씨노바이오사이언스 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 프탈라진 유도체 및 이들의 용도
US12059419B2 (en) 2020-10-16 2024-08-13 Idience Co., Ltd. Pharmaceutical composition comprising phthalazinone derivatives
WO2022087422A1 (en) * 2020-10-22 2022-04-28 Chulalongkorn University Pyrrolidine-3-carboxamide derivatives and related uses
TWI883310B (zh) * 2021-03-04 2025-05-11 南韓商愛迪恩斯股份有限公司 酞嗪酮化合物在製備用於治療人類奧拉帕尼抗藥性癌症之藥物的用途
KR20220125183A (ko) 2021-03-04 2022-09-14 아이디언스 주식회사 Parp 억제제에 내성을 가진 환자군의 암 치료제로서의 프탈라지논 유도체의 항암제 용도
KR20240016319A (ko) * 2021-06-02 2024-02-06 아이디언스 주식회사 프탈라지논 유도체를 이용한 장애 치료 방법
EP4469051A4 (en) * 2022-01-25 2025-12-17 Idience Co Ltd Pharmaceutical composition with phthalazine derivative for simultaneous administration with an anticancer agent
WO2024025389A1 (ko) * 2022-07-29 2024-02-01 아이디언스 주식회사 프탈라지논 유도체의 중간체의 제조방법
CN117229260B (zh) * 2023-11-13 2024-02-27 中国药科大学 DNA聚合酶θ与聚ADP核糖聚合酶1双靶点抑制剂及其制备方法和医药用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228960B1 (hu) 2000-10-30 2013-07-29 Kudos Pharm Ltd Ftalazinon-származékok
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
PL1633724T3 (pl) * 2003-03-12 2011-10-31 Kudos Pharm Ltd Pochodne ftalazynonu
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0610680D0 (en) * 2006-05-31 2006-07-12 Istituto Di Ricerche D Biolog Therapeutic compounds
WO2007138355A1 (en) 2006-05-31 2007-12-06 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
ES2548353T3 (es) * 2006-12-28 2015-10-15 Abbvie Inc. Inhibidores de poli(ADP-ribosa)polimerasa
CN101030723A (zh) 2007-04-04 2007-09-05 钟志华 电磁变相发动机
EP2220073B1 (en) 2007-11-15 2014-09-03 MSD Italia S.r.l. Pyridazinone derivatives as parp inhibitors
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
GB0804755D0 (en) 2008-03-14 2008-04-16 Angeletti P Ist Richerche Bio Therapeutic compounds
JP2013532683A (ja) 2010-07-27 2013-08-19 カディラ ヘルスケア リミティド ポリ(adpリボース)ポリメラーゼ−1阻害剤としての、置換4−(4−フルオロ−3−(ピペラジン−1−カルボニル)ベンジル)フタラジン−1(2h)−オン誘導体
CN102372716A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
CN102372706A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
CN102372698A (zh) 2010-08-10 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
JP5699223B2 (ja) 2010-12-02 2015-04-08 シャンハイ デュァ ノボ ファルマテック カンパニー リミテッド 複素環誘導体、その合成法および医療用途
CN102485721B (zh) 2010-12-03 2015-12-09 曹亚 取代的2,3-二氮杂萘酮化合物及其用途
CN103130723B (zh) 2011-11-30 2015-01-14 成都地奥制药集团有限公司 一种多聚(adp-核糖)聚合酶抑制剂
KR101670126B1 (ko) * 2013-09-13 2016-10-27 일동제약(주) 신규 프탈라지논 유도체 및 그 제조방법

Similar Documents

Publication Publication Date Title
JP2016534143A5 (https=)
RU2016108038A (ru) Новые фталазиновые производные и способ их получения
USRE49556E1 (en) Compounds and compositions as protein kinase inhibitors
JP5736507B2 (ja) 含窒素複素環化合物またはその塩
JP2020503299A5 (https=)
JP2016517878A5 (https=)
JP2017512794A5 (https=)
HRP20160118T1 (hr) HETEROCIKLIÄŚKI DERIVAT KAO INHIBITOR MIKROSOMSKIH SINTAZA PROSTAGLANDINA E (mPGEs)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
RU2012126987A (ru) Спироиндолциклопропаниндолиноны в качестве модуляторов амрк
JP2017530185A5 (https=)
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2
JP2019505541A5 (https=)
JP2013532713A5 (https=)
JP2019523266A5 (https=)
NZ603525A (en) Pyrimidine based compound and uses thereof
RU2005108999A (ru) Азотсодержащие ароматические производные
JP2016503009A5 (https=)
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
JP2016523935A5 (https=)
RU2017120217A (ru) 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1
HRP20160421T1 (hr) Derivat azola
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
CA2670605A1 (en) Substituted arylpyrazoles
JP2021535134A5 (https=)